Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal cellular physiology (HP:0011017)help
Grandparent Node:
expand
Abnormal lymphocyte physiology (HP:0031409)help
Parent Node:
expand
Abnormality of T cell physiology (HP:0011840)help
..Starting node
..expand
Abnormal T cell activation (HP:0410035)help
Term ID: 410035
Name: Abnormal T cell activation
Synonym: Abnormal T lymphocyte activation; Abnormal T-cell activation; Abnormal T-lymphocyte activation
Definition: Any abnormality in the activation of T cells, i.e. the change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
Comments:
Reference: HP:0410035
Genes and Diseases:
 
       Child Nodes:
........expandDecreased T cell activation (HP:0005419) help
........expandAbnormal CD69 upregulation upon TCR activation (HP:0031267) help
................... HP:0031268 Decreased CD69 upregulation upon TCR activation
........expandAbnormal CD25 upregulation upon TCR activation (HP:0031269) help
................... HP:0031270 Decreased CD25 upregulation upon TCR activation

 Sister Nodes: 
..expandAbnormal delayed hypersensitivity skin test (HP:0002963) help
..expandAbnormal T cell proliferation (HP:0031379) help
..expandImpaired T cell function (HP:0005435) help
..expandLack of T cell function (HP:0005354) help
..expandobsolete Exaggerated cellular immune processes (HP:0005397) help
..expandOligoclonal T cell expansion (HP:0031430) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0410035HP:0410035Abnormal T cell activation0CARMIL2 CL E G H14620627089OMIM:618131IMMUNODEFICIENCY 58; IMD583
HP:0410035HP:0410035Abnormal T cell activation0CASP8 CL E G H8411509OMIM:607271CASPASE 8 DEFICIENCY37
HP:0410035HP:0410035Abnormal T cell activation0CD40LG CL E G H95911935OMIM:308230Immunodeficiency, X-linked, with hyper-IgM33
HP:0410035HP:0410035Abnormal T cell activation0EPG5 CL E G H5772429331OMIM:242840Vici syndrome40
HP:0410035HP:0410035Abnormal T cell activation0LEP CL E G H39526553ORPHA:66628Obesity due to congenital leptin deficiency47
HP:0410035HP:0410035Abnormal T cell activation0LEPR CL E G H39536554ORPHA:179494Obesity due to leptin receptor gene deficiency46
HP:0410035HP:0410035Abnormal T cell activation0MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0410035HP:0410035Abnormal T cell activation0TGFB1 CL E G H704011766OMIM:618213INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE13
HP:0410035HP:0031269Abnormal CD25 upregulation upon TCR activation1 CL E G H
HP:0410035HP:0005419Decreased T cell activation1CARMIL2 CL E G H14620627089OMIM:618131IMMUNODEFICIENCY 58; IMD583
HP:0410035HP:0005419Decreased T cell activation1CASP8 CL E G H8411509OMIM:607271CASPASE 8 DEFICIENCY37
HP:0410035HP:0005419Decreased T cell activation1CD40LG CL E G H95911935OMIM:308230Immunodeficiency, X-linked, with hyper-IgM.33
HP:0410035HP:0005419Decreased T cell activation1EPG5 CL E G H5772429331OMIM:242840Vici syndrome.40
HP:0410035HP:0005419Decreased T cell activation1LEP CL E G H39526553ORPHA:66628Obesity due to congenital leptin deficiencyHP:0040281 - Very frequent47
HP:0410035HP:0005419Decreased T cell activation1LEPR CL E G H39536554ORPHA:179494Obesity due to leptin receptor gene deficiencyHP:0040281 - Very frequent46
HP:0410035HP:0005419Decreased T cell activation1MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0410035HP:0031267Abnormal CD69 upregulation upon TCR activation1MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0410035HP:0005419Decreased T cell activation1TGFB1 CL E G H704011766OMIM:618213INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE13
HP:0410035HP:0031270Decreased CD25 upregulation upon TCR activation2 CL E G H
HP:0410035HP:0031268Decreased CD69 upregulation upon TCR activation2MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17


Genes (8) :CARMIL2 CASP8 CD40LG EPG5 LEP LEPR MAGT1 TGFB1

Diseases (8) :OMIM:618131 OMIM:607271 OMIM:308230 OMIM:242840 ORPHA:66628 ORPHA:179494 OMIM:300853 OMIM:618213
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.